Samil Pharmaceutical Co.,Ltd

KOSE:A000520 Stok Raporu

Piyasa değeri: ₩324.2b

Samil PharmaceuticalLtd Temettü

Temettü kriter kontrolleri 0/6

Samil PharmaceuticalLtd does not currently pay a dividend.

Anahtar bilgiler

0%

Temettü verimi

6.8%

Geri Alım Getirisi

Toplam Hissedar Getirisi6.8%
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettü₩72.727
Ödeme oranı0%

Son temettü güncellemeleri

Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend

Dec 24
Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend

Recent updates

Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking

Sep 13
Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking

We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt

Sep 11
We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt

Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking

Jul 29
Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking

Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?

May 24
Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?

There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump

Mar 30
There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump

Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality

Mar 21
Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality

Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden

Apr 01
Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden

Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment

Mar 11
Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment

Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?

Feb 15
Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?

Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?

Jan 20
Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?

Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend

Dec 24
Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend

Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment

Dec 09
Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment

What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?

Nov 18
What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if A000520's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if A000520's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Samil PharmaceuticalLtd Piyasaya Karşı Temettü Getirisi
A000520 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (A000520)0%
Pazarın Alt %25'i (KR)1.2%
Pazarın En İyi %25'i (KR)3.8%
Sektör Ortalaması (Pharmaceuticals)1.0%
Analist tahmini (A000520) (3 yıla kadar)n/a

Önemli Temettü: Unable to evaluate A000520's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate A000520's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: A000520 is not paying a notable dividend for the KR market.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as A000520 has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin